data_1ayj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ayj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' CB ' ' SG ' ' A' ' 47' ' ' CYS . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.268 0.556 . . . . 1.0 112.291 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 120.824 0.345 . . . . 1.0 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.467 0.175 . . . . 1.0 110.763 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 111.391 0.145 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.616 0.246 . . . . 1.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.92 69.48 2.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt -96.82 146.49 24.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.108 0.563 . . . . 1.0 110.113 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.862 0.363 . . . . 1.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 71.8 3.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 1.0 108.917 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.66 149.31 29.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.98 148.28 1.76 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.456 1.102 . . . . 1.0 110.198 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.81 150.73 9.4 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.65 131.88 39.75 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.8 153.84 19.72 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -90.04 170.35 10.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp -69.37 147.18 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.512 -0.181 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -55.71 161.83 1.97 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.647 0.779 . . . . 1.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.96 149.76 49.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 169.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 125.7 29.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 173.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -53.91 147.09 12.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -63.34 121.56 14.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.37 157.63 19.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.156 0.435 . . . . 1.0 112.113 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' CB ' ' SG ' ' A' ' 47' ' ' CYS . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.24 69.01 4.38 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.1 156.43 33.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.871 0.869 . . . . 1.0 112.291 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 143.37 23.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.694 0.798 . . . . 1.0 109.337 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.02 172.44 9.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.778 0.831 . . . . 1.0 109.263 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.21 69.76 2.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.35 0.595 . . . . 1.0 109.943 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.14 169.63 13.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.379 1.471 . . . . 1.0 110.484 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 119.472 -0.299 . . . . 1.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -50.26 120.36 4.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.954 0.902 . . . . 1.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt -86.96 163.15 17.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 135.58 50.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.01 0.524 . . . . 1.0 111.429 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt -69.71 157.52 37.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -73.03 72.46 1.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt -73.22 165.38 25.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.792 0.837 . . . . 1.0 110.763 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.826 0.346 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -63.48 141.67 58.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.13 153.84 6.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 106.042 -1.836 . . . . 1.0 106.042 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.03 140.52 9.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.326 1.05 . . . . 1.0 109.018 168.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp -85.42 151.83 23.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 123.171 0.294 . . . . 1.0 111.391 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 107.533 -1.284 . . . . 1.0 107.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.66 148.02 21.11 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.381 0.272 . . . . 1.0 110.394 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.05 160.55 20.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.669 0.787 . . . . 1.0 111.626 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.24 -0.281 . . . . 1.0 110.24 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 151.94 6.78 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.073 0.549 . . . . 1.0 110.201 173.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.13 157.84 25.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.617 -0.142 . . . . 1.0 110.617 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -55.74 121.61 9.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.11 160.05 24.8 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 110.486 -0.19 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 134.62 57.19 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.72 176.26 7.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 47' ' ' CYS . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.268 0.556 . . . . 1.0 112.291 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 120.824 0.345 . . . . 1.0 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' H ' ' A' ' 36' ' ' CYS . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 18' ' ' ASN . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.467 0.175 . . . . 1.0 110.763 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 111.391 0.145 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 40' ' ' PHE . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.491 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.616 0.246 . . . . 1.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.92 69.48 2.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt -96.82 146.49 24.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.108 0.563 . . . . 1.0 110.113 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.5 tm0? -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.862 0.363 . . . . 1.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 71.8 3.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 1.0 108.917 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.66 149.31 29.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.98 148.28 1.76 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.456 1.102 . . . . 1.0 110.198 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.81 150.73 9.4 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.65 131.88 39.75 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.8 153.84 19.72 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -90.04 170.35 10.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 3' ' ' LEU . 3.6 mp -69.37 147.18 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.512 -0.181 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -55.71 161.83 1.97 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.647 0.779 . . . . 1.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.96 149.76 49.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 169.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 125.7 29.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 173.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -53.91 147.09 12.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 47' ' ' CYS . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -63.34 121.56 14.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.37 157.63 19.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.156 0.435 . . . . 1.0 112.113 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.24 69.01 4.38 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.1 156.43 33.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.871 0.869 . . . . 1.0 112.291 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 143.37 23.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.694 0.798 . . . . 1.0 109.337 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.02 172.44 9.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.778 0.831 . . . . 1.0 109.263 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.21 69.76 2.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.35 0.595 . . . . 1.0 109.943 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.14 169.63 13.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.379 1.471 . . . . 1.0 110.484 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' H ' ' A' ' 36' ' ' CYS . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 18' ' ' ASN . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 119.472 -0.299 . . . . 1.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -50.26 120.36 4.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.954 0.902 . . . . 1.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt -86.96 163.15 17.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 135.58 50.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.01 0.524 . . . . 1.0 111.429 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt -69.71 157.52 37.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -73.03 72.46 1.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt -73.22 165.38 25.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.792 0.837 . . . . 1.0 110.763 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.826 0.346 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -63.48 141.67 58.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.13 153.84 6.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 106.042 -1.836 . . . . 1.0 106.042 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.03 140.52 9.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.326 1.05 . . . . 1.0 109.018 168.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp -85.42 151.83 23.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 123.171 0.294 . . . . 1.0 111.391 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 40' ' ' PHE . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.491 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 107.533 -1.284 . . . . 1.0 107.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.66 148.02 21.11 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.381 0.272 . . . . 1.0 110.394 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.05 160.55 20.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.669 0.787 . . . . 1.0 111.626 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.24 -0.281 . . . . 1.0 110.24 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 151.94 6.78 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.073 0.549 . . . . 1.0 110.201 173.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.13 157.84 25.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.617 -0.142 . . . . 1.0 110.617 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -55.74 121.61 9.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.11 160.05 24.8 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 110.486 -0.19 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 134.62 57.19 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.72 176.26 7.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.113 -0.328 . . . . 1.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 47' ' ' CYS . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.113 0.412 . . . . 1.0 112.113 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.268 0.556 . . . . 1.0 112.291 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 120.824 0.345 . . . . 1.0 110.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' H ' ' A' ' 36' ' ' CYS . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 18' ' ' ASN . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.467 0.175 . . . . 1.0 110.763 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 111.391 0.145 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 40' ' ' PHE . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.491 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.616 0.246 . . . . 1.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 108.202 -1.036 . . . . 1.0 108.202 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.92 69.48 2.55 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 173.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.8 mt -96.82 146.49 24.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.108 0.563 . . . . 1.0 110.113 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.5 m -113.41 121.63 44.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.349 1.46 . . . . 1.0 107.098 174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -89.43 62.53 6.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.264 1.826 . . . . 1.0 108.548 -169.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 146.25 76.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.04 135.57 55.85 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 N-CA-C 102.786 -3.582 . . . . 1.0 102.786 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.7 m -42.83 138.29 2.02 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.491 0.923 . . . . 1.0 113.491 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.3 -41.33 47.41 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.27 -1.132 . . . . 1.0 110.27 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.7 p -84.1 -72.53 0.46 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.727 -0.842 . . . . 1.0 108.727 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -75.51 71.01 2.42 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.314 1.045 . . . . 1.0 110.206 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 m -87.28 63.5 7.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.053 -1.091 . . . . 1.0 108.053 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.94 -166.68 32.47 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.905 -0.664 . . . . 1.0 114.21 -174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.68 137.57 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 125.188 1.395 . . . . 1.0 109.434 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.9 p -103.91 -59.22 1.76 Allowed 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 124.366 1.066 . . . . 1.0 112.484 -170.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.62 15.15 5.75 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.687 -1.063 . . . . 1.0 115.031 -169.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -168.21 107.57 0.51 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.025 1.912 . . . . 1.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -60.87 -52.8 63.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.429 1.492 . . . . 1.0 112.564 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -54.86 -52.26 63.35 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.175 0.99 . . . . 1.0 111.32 -175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.61 -53.22 60.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.319 1.012 . . . . 1.0 109.482 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 8.7 t -48.43 -56.75 7.4 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 123.474 0.484 . . . . 1.0 110.873 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -47.24 -63.39 1.05 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.477 1.111 . . . . 1.0 110.335 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -53.34 -68.79 0.15 Allowed 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 108.991 -0.744 . . . . 1.0 108.991 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -42.0 -49.28 4.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.507 1.523 . . . . 1.0 110.965 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -56.0 -61.51 2.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.985 0.811 . . . . 1.0 111.224 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.1 pt -78.13 -15.52 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.789 0.804 . . . . 1.0 111.389 -170.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -77.84 -52.51 8.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.637 1.175 . . . . 1.0 108.208 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mp -75.01 -71.61 0.35 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.837 -0.431 . . . . 1.0 109.837 174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -86.24 -178.88 6.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.708 -1.59 . . . . 1.0 106.708 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm -113.86 13.74 18.45 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 115.211 1.56 . . . . 1.0 115.211 -167.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.52 165.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.875 1.67 . . . . 1.0 113.538 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.4 mmp_? -86.86 -74.54 0.43 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.829 -0.544 . . . . 1.0 112.309 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -108.31 165.72 11.29 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.004 0.522 . . . . 1.0 110.103 169.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.48 162.0 28.75 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 107.609 -2.196 . . . . 1.0 107.609 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 m -169.78 155.17 5.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.357 1.078 . . . . 1.0 109.669 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.8 t -84.34 61.06 6.36 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.907 1.283 . . . . 1.0 108.88 -175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -62.03 151.7 34.56 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.206 -173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -83.22 -123.57 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.204 1.002 . . . . 1.0 111.402 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.6 t 69.24 154.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 126.842 2.057 . . . . 1.0 107.963 -167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -52.65 150.64 9.09 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.417 -0.802 . . . . 1.0 110.889 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.58 -53.64 0.14 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.899 -0.846 . . . . 1.0 109.899 -9.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.16 176.14 5.19 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.245 1.818 . . . . 1.0 109.541 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -64.78 148.08 51.9 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 110.214 -0.291 . . . . 1.0 110.214 172.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.01 152.91 40.88 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.575 0.75 . . . . 1.0 110.313 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.9 t -76.34 83.06 3.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.264 -0.175 . . . . 1.0 111.027 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.2 mm -78.48 141.19 15.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.6 t -142.65 141.26 31.85 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.743 -0.662 . . . . 1.0 110.443 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -102.32 99.71 9.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.843 1.257 . . . . 1.0 110.227 -167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.19 137.62 22.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.372 -0.823 . . . . 1.0 109.012 178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.77 74.84 2.74 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 124.845 3.697 . . . . 1.0 110.559 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--N 1.327 -0.413 0 C-N-CA 125.619 1.568 . . . . 1.0 111.492 -175.499 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.377 0 CA-C-O 120.862 0.363 . . . . 1.0 110.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 71.8 3.5 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 1.0 108.917 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -109.66 149.31 29.9 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 95.9 m -89.64 124.76 34.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.811 -1.181 . . . . 1.0 107.811 170.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -78.88 99.72 6.89 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.212 1.405 . . . . 1.0 108.128 172.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -87.72 118.05 69.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.058 -1.46 . . . . 1.0 107.058 173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.94 -54.82 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.962 1.775 . . . . 1.0 108.121 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -72.31 82.38 1.04 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.8 -96.85 0.32 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 106.75 -2.54 . . . . 1.0 106.75 173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -109.71 -68.23 0.94 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.995 -2.224 . . . . 1.0 104.995 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -64.79 73.47 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 127.629 2.372 . . . . 1.0 110.014 175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.57 62.8 6.7 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.096 -1.076 . . . . 1.0 108.096 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.78 -166.83 23.31 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -59.15 128.68 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.156 -1.053 . . . . 1.0 108.156 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.82 -29.47 61.08 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.899 1.074 . . . . 1.0 113.899 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.78 -45.14 0.67 Allowed Glycine 0 CA--C 1.538 1.485 0 CA-C-N 118.537 0.608 . . . . 1.0 114.257 -174.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -170.79 136.75 1.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.882 1.341 . . . . 1.0 110.885 -169.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -52.31 -62.57 1.55 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.594 1.557 . . . . 1.0 113.371 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.69 -44.03 81.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.338 -0.847 . . . . 1.0 111.317 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.33 -57.45 12.84 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.192 -0.299 . . . . 1.0 110.192 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.6 -53.84 21.72 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.234 0.614 . . . . 1.0 110.347 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -50.16 -64.53 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.355 1.862 . . . . 1.0 110.368 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -52.02 -64.13 0.92 Allowed 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -46.12 -48.78 17.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.826 0.85 . . . . 1.0 110.908 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.12 -61.95 2.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 118.959 0.8 . . . . 1.0 111.272 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 pt -74.68 -15.81 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.527 0.68 . . . . 1.0 111.284 -169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -79.45 -56.15 4.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.918 1.287 . . . . 1.0 108.098 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -71.0 -69.43 0.37 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.526 0.33 . . . . 1.0 110.39 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -88.3 178.23 6.64 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -108.17 12.94 26.27 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.128 1.158 . . . . 1.0 114.128 -168.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.79 156.16 0.09 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.452 0.701 . . . . 1.0 110.009 168.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.68 -64.7 1.1 Allowed 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.696 -0.627 . . . . 1.0 111.529 -169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -107.29 161.54 14.7 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.756 -0.831 . . . . 1.0 108.756 168.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.66 159.43 28.03 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 m -169.86 146.71 3.22 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.489 1.145 . . . . 1.0 108.146 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -81.38 136.03 35.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.922 -0.77 . . . . 1.0 108.922 170.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -116.03 153.26 32.0 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.613 1.565 . . . . 1.0 107.749 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -82.02 -123.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.855 -0.795 . . . . 1.0 108.855 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.0 t 68.87 153.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 126.457 1.903 . . . . 1.0 108.535 -169.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -51.18 151.0 5.26 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.518 -0.739 . . . . 1.0 111.162 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -81.49 -51.99 0.15 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.998 0 N-CA-C 109.324 -1.068 . . . . 1.0 109.324 -10.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -118.28 176.04 5.42 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.635 1.574 . . . . 1.0 110.662 -173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -64.12 124.1 20.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.206 1.002 . . . . 1.0 108.445 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.2 ptpp? -126.63 138.92 53.5 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.915 1.286 . . . . 1.0 110.476 -169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.0 t -76.42 123.8 26.55 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.5 mm -107.57 139.85 27.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -133.67 143.06 48.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.874 -0.33 . . . . 1.0 111.564 172.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -109.41 119.29 39.01 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.972 1.309 . . . . 1.0 111.661 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -117.99 146.09 38.31 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 125.066 1.347 . . . . 1.0 107.916 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -60.3 -27.44 84.87 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 124.757 3.638 . . . . 1.0 113.006 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.7 t . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 125.756 1.622 . . . . 1.0 113.57 168.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.98 148.28 1.76 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.456 1.102 . . . . 1.0 110.198 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 49.9 mt -54.81 150.73 9.4 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -127.75 141.92 51.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.02 145.14 28.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.761 1.224 . . . . 1.0 112.573 -169.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -126.84 111.05 22.24 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 168.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 -62.42 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.553 2.168 . . . . 1.0 109.091 170.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.5 p -74.72 82.6 2.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 171.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.78 -58.53 4.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 106.051 -2.82 . . . . 1.0 106.051 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.2 p -142.16 -70.38 0.35 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.893 2.477 . . . . 1.0 105.271 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -68.85 81.43 0.3 Allowed 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.949 2.5 . . . . 1.0 111.629 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -88.42 -10.74 48.21 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.024 -173.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.87 -158.3 21.87 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.954 1.264 . . . . 1.0 112.648 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.7 122.91 12.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -74.78 -29.74 61.22 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 123.271 0.628 . . . . 1.0 112.276 -172.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.86 -43.46 0.79 Allowed Glycine 0 CA--C 1.537 1.408 0 CA-C-O 119.459 -0.634 . . . . 1.0 114.373 -178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -170.81 134.25 1.0 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.963 1.382 . . . . 1.0 111.703 -169.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.03 -61.62 1.97 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 126.074 1.749 . . . . 1.0 113.358 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -57.63 -48.74 78.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 1.0 111.097 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.38 -51.7 67.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -56.89 10.51 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.446 0.641 . . . . 1.0 110.781 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -49.54 -62.08 1.75 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.305 1.842 . . . . 1.0 109.651 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -48.65 -64.79 0.7 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.994 1.318 . . . . 1.0 108.759 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -50.04 -45.55 52.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.245 -0.884 . . . . 1.0 111.678 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t -60.0 -57.95 10.66 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.154 1.343 . . . . 1.0 112.171 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -73.29 -15.6 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.449 0.642 . . . . 1.0 111.776 -172.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -83.62 -55.56 4.22 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.706 1.602 . . . . 1.0 108.792 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.73 -65.55 0.7 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.913 0.485 . . . . 1.0 110.205 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.75 -178.39 5.5 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.569 -1.271 . . . . 1.0 107.569 171.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -109.31 13.32 24.32 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 113.996 1.11 . . . . 1.0 113.996 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.98 156.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.677 1.591 . . . . 1.0 113.13 169.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -87.81 -60.17 2.04 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 122.034 -0.416 . . . . 1.0 110.508 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -106.72 164.41 12.11 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.679 0.752 . . . . 1.0 109.923 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.13 24.93 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 105.706 -2.957 . . . . 1.0 105.706 168.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -173.1 151.79 2.18 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.335 -1.728 . . . . 1.0 106.335 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.4 t -95.99 142.05 28.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 119.011 -0.519 . . . . 1.0 109.943 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.4 t30 -130.41 160.93 32.55 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.715 0.806 . . . . 1.0 109.159 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.45 100.81 1.45 Allowed 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.992 -0.442 . . . . 1.0 110.418 172.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.0 t -139.52 169.96 16.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -56.56 148.12 46.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.973 0.509 . . . . 1.0 109.966 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.45 -41.02 1.02 Allowed 'Cis proline' 0 N--CA 1.453 -0.872 0 CA-C-N 120.301 1.143 . . . . 1.0 111.469 0.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.68 81.56 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.4 m80 87.97 117.24 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 126.455 1.902 . . . . 1.0 106.865 -170.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.6 tttp -132.17 139.05 48.24 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.246 1.018 . . . . 1.0 108.829 -173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 35.6 t -67.29 140.96 57.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.982 -0.748 . . . . 1.0 108.982 173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mm -121.48 139.4 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 105.486 -2.042 . . . . 1.0 105.486 169.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.91 152.08 49.77 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.319 -0.848 . . . . 1.0 110.251 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -139.89 136.46 33.93 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.271 0.942 . . . . 1.0 112.903 -169.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -130.64 148.6 70.71 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 126.628 1.971 . . . . 1.0 107.257 -173.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.41 124.82 14.94 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.307 2.671 . . . . 1.0 108.641 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.455 -0.195 0 O-C-N 121.488 -0.758 . . . . 1.0 110.642 -169.504 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -53.65 131.88 39.75 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 169.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt -59.8 153.84 19.72 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.927 0.714 . . . . 1.0 112.927 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.7 m -128.88 142.2 51.03 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 127.369 2.267 . . . . 1.0 105.236 168.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -87.55 133.22 33.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.054 0.942 . . . . 1.0 109.551 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.5 120.31 13.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -47.05 131.77 17.5 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.876 1.717 . . . . 1.0 109.469 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.6 p -46.78 -47.43 20.86 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.723 0.409 . . . . 1.0 112.032 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.74 -30.05 6.87 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.787 -1.325 . . . . 1.0 109.787 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -82.62 -45.17 14.88 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -125.57 64.24 1.18 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.616 1.198 . . . . 1.0 110.721 -171.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.5 m -88.66 2.31 53.47 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.542 -1.208 . . . . 1.0 111.09 174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.19 -159.98 9.42 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.047 1.308 . . . . 1.0 110.828 169.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.73 122.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.069 -1.086 . . . . 1.0 108.069 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -35.68 64.47 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.719 0.69 . . . . 1.0 111.553 -170.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.97 -48.86 1.73 Allowed Glycine 0 CA--C 1.535 1.335 0 CA-C-O 119.182 -0.788 . . . . 1.0 113.672 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -163.1 133.23 4.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.355 1.578 . . . . 1.0 113.6 -169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -48.07 -61.17 2.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.379 1.872 . . . . 1.0 112.731 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -59.2 -48.1 82.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.317 0.647 . . . . 1.0 111.92 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.26 -54.41 43.86 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -50.72 -53.33 32.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 123.641 0.588 . . . . 1.0 110.862 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -51.01 -62.01 1.88 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.725 1.61 . . . . 1.0 109.85 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -52.91 -61.44 2.29 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.75 1.281 . . . . 1.0 107.797 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -43.34 -52.43 5.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 118.433 -0.794 . . . . 1.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -58.08 -58.54 7.97 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.083 0.856 . . . . 1.0 110.899 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.1 pt -73.72 -16.67 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 119.7 -0.8 . . . . 1.0 111.716 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -80.49 -53.69 6.35 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.417 -0.957 . . . . 1.0 108.417 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.96 -76.24 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.521 0.728 . . . . 1.0 109.135 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -86.44 178.21 7.19 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.512 -1.292 . . . . 1.0 107.512 -177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.319 15.5 mmtm -108.21 16.73 22.98 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.511 1.671 . . . . 1.0 115.511 -166.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.53 -164.79 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.103 1.361 . . . . 1.0 113.141 168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -132.35 -53.72 0.96 Allowed 'General case' 0 N--CA 1.463 0.192 0 O-C-N 120.219 -1.551 . . . . 1.0 112.254 -170.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.85 169.85 8.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.08 -0.711 . . . . 1.0 109.08 167.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.94 149.9 19.33 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 106.97 -2.452 . . . . 1.0 106.97 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.6 m -167.54 177.21 6.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.611 1.164 . . . . 1.0 108.666 -176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -123.63 153.3 40.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.388 -0.967 . . . . 1.0 108.388 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -143.6 160.07 41.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.927 -2.249 . . . . 1.0 104.927 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -64.05 108.64 1.58 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.934 0.788 . . . . 1.0 109.391 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 19.7 t -137.55 157.9 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 104.044 -2.576 . . . . 1.0 104.044 169.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -56.49 148.94 42.04 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 117.924 0.329 . . . . 1.0 110.713 -174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.06 -35.37 2.92 Favored 'Cis proline' 0 N--CA 1.452 -0.947 0 N-CA-C 110.039 -0.793 . . . . 1.0 110.039 -8.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.6 65.68 0.17 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.508 0.723 . . . . 1.0 109.755 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.3 m80 92.71 135.43 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 127.801 2.44 . . . . 1.0 109.714 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -122.76 155.69 36.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.277 1.431 . . . . 1.0 107.682 169.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.17 101.15 7.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.324 -0.991 . . . . 1.0 108.324 171.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.5 mm -86.88 121.4 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.998 -1.853 . . . . 1.0 105.998 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -102.65 152.89 20.67 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -132.36 137.25 47.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.209 0.604 . . . . 1.0 109.716 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -138.13 142.81 36.86 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 107.42 -1.326 . . . . 1.0 107.42 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.17 127.13 18.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.29 3.327 . . . . 1.0 109.121 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.283 0 CA-C-N 118.222 0.464 . . . . 1.0 111.439 -169.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -90.04 170.35 10.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.417 ' H ' HD12 ' A' ' 3' ' ' LEU . 3.6 mp -69.37 147.18 51.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.115 0.483 . . . . 1.0 109.854 171.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.3 m -90.22 105.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.215 -1.402 . . . . 1.0 107.215 170.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 119.89 11.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.67 1.188 . . . . 1.0 109.684 169.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.28 143.82 47.16 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 172.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -52.94 140.45 58.7 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.062 -1.938 . . . . 1.0 107.062 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 t -41.55 134.7 2.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.717 1.144 . . . . 1.0 112.276 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.82 -44.14 55.08 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.156 -1.177 . . . . 1.0 110.156 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 p -84.15 -58.26 2.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -86.63 67.1 9.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.987 0.899 . . . . 1.0 109.097 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.4 m -87.72 66.28 8.79 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -165.96 -169.15 29.19 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.206 -0.757 . . . . 1.0 111.206 -175.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -57.89 140.87 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.77 -37.38 67.65 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 114.294 1.22 . . . . 1.0 114.294 -168.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -50.52 0.99 Allowed Glycine 0 CA--C 1.539 1.555 0 CA-C-N 119.072 0.851 . . . . 1.0 113.96 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -171.71 132.56 0.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.7 1.25 . . . . 1.0 111.444 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -49.55 -63.23 1.17 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.066 1.746 . . . . 1.0 113.57 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -57.47 -48.84 78.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.676 0.79 . . . . 1.0 111.213 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.24 60.41 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.024 -0.361 . . . . 1.0 110.024 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 t -50.13 -58.63 5.15 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.579 0.751 . . . . 1.0 110.935 178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -47.67 -62.48 1.43 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.178 1.791 . . . . 1.0 109.874 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -52.61 -66.2 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.017 -177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -50.72 -44.92 58.32 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 118.846 -0.597 . . . . 1.0 111.084 -174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -54.42 -64.12 0.93 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 119.804 -0.758 . . . . 1.0 111.828 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -77.22 -16.56 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.641 0.734 . . . . 1.0 111.142 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -76.93 -55.36 5.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -71.46 -70.14 0.34 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -87.65 164.46 16.03 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.5 12.71 17.82 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -167.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.66 160.3 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.165 1.386 . . . . 1.0 112.854 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -83.5 -78.8 0.21 Allowed 'General case' 0 C--N 1.34 0.186 0 O-C-N 121.858 -0.526 . . . . 1.0 111.076 -176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -107.88 168.37 9.32 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.534 0.734 . . . . 1.0 109.875 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.27 163.29 29.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 107.539 -2.224 . . . . 1.0 107.539 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.1 m -170.57 158.29 6.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.819 1.247 . . . . 1.0 108.789 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.0 t -87.56 124.86 33.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.545 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -102.59 154.29 19.27 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.85 1.26 . . . . 1.0 108.969 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -123.64 47.6 2.0 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.472 1.286 . . . . 1.0 114.472 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.3 t -67.57 147.21 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.129 -2.545 . . . . 1.0 104.129 166.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -57.29 160.65 6.49 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 118.83 0.741 . . . . 1.0 111.533 -176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -83.33 -41.73 0.66 Allowed 'Cis proline' 0 N--CA 1.455 -0.788 0 CA-C-N 119.798 0.963 . . . . 1.0 110.21 -10.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.65 159.08 17.43 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.188 1.395 . . . . 1.0 111.472 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -64.47 139.68 58.79 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 126.138 1.775 . . . . 1.0 111.099 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -122.51 123.96 42.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.417 1.087 . . . . 1.0 109.655 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.4 t -77.49 92.07 3.98 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.2 mm -82.29 142.41 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -138.0 149.14 45.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 174.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.12 114.4 21.91 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.46 0.304 . . . . 1.0 110.247 -168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -100.28 149.42 36.04 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -65.48 137.79 52.21 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.956 1.771 . . . . 1.0 107.874 169.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 -177.315 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.512 -0.181 . . . . 1.0 110.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -55.71 161.83 1.97 Allowed 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.647 0.779 . . . . 1.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.8 mt -64.96 149.76 49.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 169.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.82 110.73 22.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.018 -2.216 . . . . 1.0 105.018 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -74.7 69.64 1.8 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.866 -1.161 . . . . 1.0 107.866 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.82 111.66 4.2 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 126.346 1.859 . . . . 1.0 111.016 -169.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.2 -77.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.619 1.546 . . . . 1.0 108.512 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 m -84.01 151.57 24.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.405 1.082 . . . . 1.0 112.507 -174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.09 -86.47 0.09 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 106.807 -2.517 . . . . 1.0 106.807 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -86.09 -96.31 0.08 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 169.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.32 91.91 0.4 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -105.15 63.96 0.71 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.517 1.127 . . . . 1.0 109.809 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.62 -166.48 36.32 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.764 -0.731 . . . . 1.0 112.577 -176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.0 147.37 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.783 1.233 . . . . 1.0 109.081 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -120.32 -56.11 2.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.212 1.005 . . . . 1.0 112.515 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 52.4 20.61 7.44 Favored Glycine 0 CA--C 1.539 1.568 0 CA-C-O 118.901 -0.944 . . . . 1.0 114.65 -171.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -165.62 106.83 0.75 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.67 1.735 . . . . 1.0 112.258 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -55.25 -60.47 3.35 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.604 1.161 . . . . 1.0 113.0 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -51.02 -52.07 46.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.705 1.602 . . . . 1.0 111.553 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.85 -50.22 71.81 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 t -53.04 -54.99 27.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.056 0.455 . . . . 1.0 110.835 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -48.01 -62.85 1.26 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.417 1.487 . . . . 1.0 109.88 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -53.93 -62.42 1.67 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 108.195 -1.039 . . . . 1.0 108.195 -174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -50.66 -42.96 57.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.819 -0.61 . . . . 1.0 111.113 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.4 t -56.99 -64.22 0.95 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 118.863 -1.135 . . . . 1.0 111.658 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.2 pt -71.1 -15.16 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.524 0.678 . . . . 1.0 111.574 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -82.76 -61.12 1.96 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.799 1.64 . . . . 1.0 109.043 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.55 -45.0 66.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.238 0.472 . . . . 1.0 111.488 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -105.69 176.6 5.11 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 107.051 -1.463 . . . . 1.0 107.051 169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.27 12.64 35.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.823 1.046 . . . . 1.0 113.823 -169.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.08 163.77 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.427 1.491 . . . . 1.0 114.462 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -88.0 -72.89 0.51 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-O 118.386 -0.816 . . . . 1.0 111.276 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -108.55 167.82 9.77 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.987 0.812 . . . . 1.0 111.778 172.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.2 159.32 29.96 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 107.835 -2.106 . . . . 1.0 107.835 172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -166.45 148.74 6.73 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 118.501 1.151 . . . . 1.0 110.876 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 51.0 t -77.73 65.78 3.28 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.81 -1.086 . . . . 1.0 108.308 174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -65.51 147.68 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -63.93 130.53 44.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.9 t -152.33 161.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 102.97 -2.974 . . . . 1.0 102.97 169.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -58.25 149.04 60.32 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.32 -46.46 0.36 Allowed 'Cis proline' 0 N--CA 1.45 -1.052 0 CA-C-N 119.867 0.988 . . . . 1.0 109.839 -8.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 67.01 1.26 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.389 1.075 . . . . 1.0 109.316 -173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 75.97 154.48 0.15 Allowed 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.317 1.447 . . . . 1.0 111.352 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -141.97 150.77 41.82 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.05 84.51 1.79 Allowed 'General case' 0 C--O 1.232 0.145 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.108 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mm -84.4 126.51 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -105.35 148.43 27.08 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 119.145 -0.455 . . . . 1.0 109.889 175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -130.83 105.26 7.66 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.286 0.565 . . . . 1.0 109.811 -169.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -139.17 147.9 55.12 Favored Pre-proline 0 N--CA 1.457 -0.107 0 C-N-CA 124.238 1.015 . . . . 1.0 109.969 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.71 138.44 59.29 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.47 2.78 . . . . 1.0 111.024 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -179.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 108.201 -1.037 . . . . 1.0 108.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.71 125.7 29.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 173.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 mp -53.91 147.09 12.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.14 0.495 . . . . 1.0 110.738 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.6 m -83.71 112.98 20.56 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.576 -1.268 . . . . 1.0 107.576 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.44 70.3 7.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.387 1.875 . . . . 1.0 109.113 -172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.9 123.7 89.88 Favored Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 -173.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.95 -160.98 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.004 2.469 . . . . 1.0 110.979 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -59.54 83.29 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.596 1.558 . . . . 1.0 111.918 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -124.1 24.36 6.32 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.756 1.646 . . . . 1.0 110.685 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -156.21 -58.31 0.09 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 103.745 -2.687 . . . . 1.0 103.745 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 18.3 t-105 -65.14 145.18 56.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.057 -2.201 . . . . 1.0 105.057 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.4 m -98.12 117.57 32.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.492 0.317 . . . . 1.0 110.971 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.37 -136.35 32.06 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 122.935 0.302 . . . . 1.0 113.002 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.4 t -67.0 138.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.46 0.704 . . . . 1.0 109.719 -170.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.17 -34.37 63.77 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.772 0.656 . . . . 1.0 112.772 -169.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.66 -52.67 1.97 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 119.546 -0.586 . . . . 1.0 113.51 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -156.92 133.59 10.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.713 1.256 . . . . 1.0 112.587 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -44.62 -63.51 0.89 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.387 1.875 . . . . 1.0 113.263 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.34 -44.17 97.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.872 0.869 . . . . 1.0 111.809 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.61 56.32 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -54.19 -51.21 65.11 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.642 0.258 . . . . 1.0 110.734 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -48.32 -62.8 1.3 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.765 1.626 . . . . 1.0 110.463 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -51.64 -64.81 0.69 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -53.68 -41.27 66.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 119.076 -0.488 . . . . 1.0 111.244 -172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -55.74 -67.53 0.28 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.603 0.638 . . . . 1.0 111.677 174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -71.13 -15.16 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.289 0.566 . . . . 1.0 111.413 -169.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -80.75 -63.65 1.36 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.149 1.38 . . . . 1.0 109.362 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.41 -56.46 5.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.958 0.503 . . . . 1.0 110.645 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.24 173.31 8.47 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 13.55 24.72 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.697 -1.252 . . . . 1.0 113.991 -168.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.28 161.31 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.709 1.604 . . . . 1.0 112.923 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -82.75 -76.61 0.26 Allowed 'General case' 0 C--N 1.339 0.146 0 CA-C-O 119.112 -0.47 . . . . 1.0 111.214 -177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.5 p-80 -107.46 154.6 21.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.342 0.591 . . . . 1.0 110.295 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 47' ' ' CYS . . . -135.22 155.65 22.2 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 107.419 -2.273 . . . . 1.0 107.419 169.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.31 100.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 -172.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.5 t -73.33 145.72 45.78 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.923 -0.58 . . . . 1.0 109.741 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.29 167.22 16.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.697 1.999 . . . . 1.0 107.942 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -74.95 68.23 1.77 Allowed 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.99 0.9 . . . . 1.0 109.678 169.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -74.97 100.04 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 105.531 -2.026 . . . . 1.0 105.531 169.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -41.41 150.09 0.35 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.826 1.65 . . . . 1.0 113.198 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -84.2 -36.52 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.791 0 CA-C-N 119.803 0.966 . . . . 1.0 111.58 -5.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.55 147.65 32.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.518 1.127 . . . . 1.0 109.197 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -63.14 137.51 58.25 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.836 1.255 . . . . 1.0 109.957 -174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -119.72 140.33 50.86 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.595 1.158 . . . . 1.0 108.025 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.2 t -74.03 83.11 1.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 -175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.0 mm -78.2 121.51 31.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.134 -1.061 . . . . 1.0 108.134 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 11.4 t -124.44 141.25 52.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.92 0.888 . . . . 1.0 109.846 175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -106.08 103.71 13.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.122 0.569 . . . . 1.0 110.039 -168.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.1 m-30 -94.56 144.56 28.12 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -63.31 131.65 32.95 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.733 -1.679 . . . . 1.0 107.733 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.006 -1.479 . . . . 1.0 107.006 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 106.925 -1.509 . . . . 1.0 106.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -63.34 121.56 14.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.37 157.63 19.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.156 0.435 . . . . 1.0 112.113 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.8 m -122.81 136.67 54.95 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 104.63 -2.359 . . . . 1.0 104.63 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.8 137.45 35.87 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.646 1.179 . . . . 1.0 109.621 -171.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -136.26 157.68 75.08 Favored Pre-proline 0 N--CA 1.456 -0.172 0 C-N-CA 123.871 0.868 . . . . 1.0 109.575 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.61 149.86 56.0 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 N-CA-C 105.126 -2.682 . . . . 1.0 105.126 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.3 p -24.65 -69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.685 1.994 . . . . 1.0 114.87 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.81 -34.18 3.4 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.093 0.854 . . . . 1.0 111.292 -173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -83.74 -72.6 0.45 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.66 -1.608 . . . . 1.0 106.66 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -65.63 77.32 0.07 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.839 1.656 . . . . 1.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.4 m -88.32 64.15 7.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 -170.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.63 -172.97 40.16 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.86 . . . . 1.0 110.949 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.8 t -58.64 146.65 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 108.544 -0.91 . . . . 1.0 108.544 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -35.97 67.71 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.509 0.929 . . . . 1.0 113.509 -168.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.01 -44.67 0.54 Allowed Glycine 0 CA--C 1.54 1.616 0 CA-C-O 119.07 -0.85 . . . . 1.0 114.878 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -172.35 131.47 0.6 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.563 1.681 . . . . 1.0 112.441 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -55.62 -60.73 3.03 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.622 1.569 . . . . 1.0 113.744 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -53.03 -48.47 67.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.448 1.099 . . . . 1.0 112.066 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.46 -53.7 53.03 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.963 -0.384 . . . . 1.0 109.963 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -47.76 -53.54 14.96 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.238 0.615 . . . . 1.0 110.628 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 ttmm -51.41 -63.98 0.96 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.372 1.869 . . . . 1.0 110.064 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -51.27 -62.43 1.62 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 124.107 0.879 . . . . 1.0 109.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -52.32 -46.05 65.84 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.97 -0.538 . . . . 1.0 111.14 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.32 -64.36 0.92 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 119.627 -0.829 . . . . 1.0 111.505 177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.4 pt -68.9 -15.36 19.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 112.14 0.422 . . . . 1.0 112.14 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -84.0 -58.3 2.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.399 1.48 . . . . 1.0 109.075 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -69.89 -63.6 1.05 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.106 0.562 . . . . 1.0 109.914 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 -177.92 5.82 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.886 -1.524 . . . . 1.0 106.886 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -109.13 11.13 25.79 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.35 -0.844 . . . . 1.0 112.72 -168.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -47.71 144.8 3.08 Favored 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 108.42 -0.955 . . . . 1.0 108.42 168.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -95.46 -34.92 11.9 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.477 1.035 . . . . 1.0 111.09 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -108.29 151.85 25.41 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.194 -1.039 . . . . 1.0 108.194 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.27 147.95 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 105.113 -3.195 . . . . 1.0 105.113 169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.56 133.23 0.78 Allowed 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.026 1.413 . . . . 1.0 107.921 -173.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 29.6 t -74.57 139.92 44.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 170.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -133.21 152.55 51.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -64.42 137.06 57.68 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -174.49 167.72 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 104.184 -2.524 . . . . 1.0 104.184 171.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -55.88 149.94 30.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 110.377 -0.231 . . . . 1.0 110.377 -177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.71 -39.02 1.56 Allowed 'Cis proline' 0 N--CA 1.448 -1.179 0 N-CA-C 108.956 -1.209 . . . . 1.0 108.956 -10.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.0 55.93 0.3 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.987 -0.53 . . . . 1.0 111.033 -169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.0 m80 99.22 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.798 2.439 . . . . 1.0 111.044 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.7 mttp -119.99 151.02 39.59 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.8 t -82.25 106.79 14.43 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.524 1.13 . . . . 1.0 108.586 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.24 151.38 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' ' CB ' ' A' ' 31' ' ' ALA . 3.2 t -145.38 151.96 39.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 111.902 0.334 . . . . 1.0 111.902 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -141.09 134.38 29.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.866 0.691 . . . . 1.0 112.866 -167.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -122.07 142.75 37.26 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 126.514 1.925 . . . . 1.0 107.685 -176.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -59.23 127.68 24.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.703 2.936 . . . . 1.0 107.848 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -168.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -78.24 69.01 4.38 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.1 mt -76.1 156.43 33.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.871 0.869 . . . . 1.0 112.291 -169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 59.8 m -127.93 124.9 38.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.602 -1.999 . . . . 1.0 105.602 169.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -79.61 92.79 5.38 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -90.43 119.48 69.13 Favored Pre-proline 0 N--CA 1.453 -0.304 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.84 -73.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.606 1.538 . . . . 1.0 109.301 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.39 82.65 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.376 -0.828 . . . . 1.0 109.528 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.41 -49.41 3.24 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 107.335 -2.306 . . . . 1.0 107.335 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.4 -59.75 0.68 Allowed 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.858 -1.905 . . . . 1.0 105.858 169.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -64.89 73.02 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.71 1.604 . . . . 1.0 112.536 -176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.6 m -89.29 61.58 5.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.865 0.866 . . . . 1.0 108.874 -175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.28 -173.58 41.17 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.975 -0.85 . . . . 1.0 110.975 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.85 133.22 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.68 -31.44 61.91 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.49 -48.47 1.22 Allowed Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.577 -0.569 . . . . 1.0 113.446 -172.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -167.37 139.4 3.24 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.804 1.302 . . . . 1.0 111.866 -169.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -55.41 -60.98 2.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.46 1.504 . . . . 1.0 113.095 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -52.14 -47.46 65.37 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.777 0.831 . . . . 1.0 111.452 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.74 -54.2 49.14 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 117.921 0.328 . . . . 1.0 110.621 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.82 -57.37 7.51 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.14 0.576 . . . . 1.0 111.042 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -47.89 -62.64 1.36 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.044 1.738 . . . . 1.0 109.908 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -55.07 -64.72 0.75 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.139 -0.937 . . . . 1.0 108.539 -174.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -51.69 -43.14 62.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 118.26 -0.876 . . . . 1.0 110.649 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.1 -65.22 0.62 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.196 0.907 . . . . 1.0 111.716 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.4 pt -73.77 -16.61 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.858 0.837 . . . . 1.0 111.582 -169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -77.3 -55.32 5.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.834 1.254 . . . . 1.0 107.964 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.71 -73.81 0.15 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -86.66 164.39 16.82 Favored 'General case' 0 C--O 1.224 -0.258 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.89 12.71 18.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 120.48 -1.388 . . . . 1.0 113.388 -168.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.95 155.54 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.302 1.441 . . . . 1.0 112.999 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.69 -68.23 0.81 Allowed 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.961 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -107.68 162.37 14.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.241 0.543 . . . . 1.0 109.838 169.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.04 160.93 30.07 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 107.175 -2.37 . . . . 1.0 107.175 172.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -173.68 142.05 0.89 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.17 139.04 34.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.442 -0.948 . . . . 1.0 108.442 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -125.2 159.82 30.66 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.427 1.079 . . . . 1.0 109.099 170.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -98.12 132.36 43.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.48 0.657 . . . . 1.0 110.817 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 t -152.19 156.7 5.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 101.611 -3.477 . . . . 1.0 101.611 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -54.93 154.47 9.74 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.232 1.378 . . . . 1.0 111.158 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.27 -43.44 0.63 Allowed 'Cis proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.739 -0.908 . . . . 1.0 109.739 -10.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.06 172.19 9.19 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.007 1.323 . . . . 1.0 111.932 -171.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -63.44 130.15 43.2 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.202 1.401 . . . . 1.0 108.436 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 ptpp? -132.13 136.61 47.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.657 0.783 . . . . 1.0 111.656 -168.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.0 t -76.35 128.3 34.58 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.182 0.993 . . . . 1.0 109.567 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.3 mm -114.83 137.04 49.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 106.872 -1.529 . . . . 1.0 106.872 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.9 t -132.71 142.25 48.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 117.822 0.283 . . . . 1.0 111.453 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -112.85 114.27 26.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.346 1.059 . . . . 1.0 110.085 -169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.78 154.41 72.93 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.379 1.072 . . . . 1.0 109.337 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.53 52.28 4.27 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.44 2.76 . . . . 1.0 111.939 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 C-N-CA 126.621 1.968 . . . . 1.0 113.958 -169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 105.633 -1.988 . . . . 1.0 105.633 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 143.37 23.69 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.694 0.798 . . . . 1.0 109.337 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.02 172.44 9.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.778 0.831 . . . . 1.0 109.263 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.05 145.11 50.46 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.949 -1.5 . . . . 1.0 106.949 169.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -93.94 150.61 20.21 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 1.0 111.483 -171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.35 117.42 12.36 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 167.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -56.57 -50.85 10.56 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.383 2.055 . . . . 1.0 111.294 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.3 p -70.46 -83.01 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.336 0.589 . . . . 1.0 109.462 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.36 -56.9 2.86 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 108.764 -1.734 . . . . 1.0 108.764 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 p -144.7 -62.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 129.637 3.175 . . . . 1.0 106.143 169.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -64.82 79.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.589 1.956 . . . . 1.0 111.479 -174.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.4 m -87.93 64.6 7.92 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 179.67 -168.81 39.48 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 112.303 -0.319 . . . . 1.0 112.303 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.35 130.15 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.52 1.128 . . . . 1.0 108.646 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.5 p -85.93 -49.02 8.18 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.703 0.801 . . . . 1.0 110.989 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.27 -56.33 1.14 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.316 0.484 . . . . 1.0 112.663 -170.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -119.27 115.79 24.9 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.465 1.506 . . . . 1.0 112.235 -169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -49.39 -60.02 3.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.539 1.535 . . . . 1.0 112.132 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -51.89 -47.88 64.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.741 -1.118 . . . . 1.0 111.455 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.11 -57.31 13.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 119.243 -0.408 . . . . 1.0 110.245 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -52.6 49.63 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.404 0.44 . . . . 1.0 110.584 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -49.67 -66.3 0.42 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.166 1.386 . . . . 1.0 110.598 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -53.46 -62.47 1.63 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.729 -1.211 . . . . 1.0 107.729 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -44.3 -51.06 8.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.811 0.844 . . . . 1.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.3 t -54.8 -60.96 2.65 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.85 0.75 . . . . 1.0 111.108 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 pt -78.14 -15.49 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.766 0.793 . . . . 1.0 111.694 -169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -80.9 -52.94 6.91 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.086 1.354 . . . . 1.0 108.108 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -69.81 -74.74 0.13 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -87.59 178.41 6.78 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.0 107.265 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.278 14.5 mmtm -107.99 14.47 25.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 115.361 1.615 . . . . 1.0 115.361 -167.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.36 163.75 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.725 1.21 . . . . 1.0 112.136 168.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.8 mmp_? -84.98 -77.42 0.28 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.388 -0.82 . . . . 1.0 111.618 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -108.18 167.62 9.88 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.224 0.61 . . . . 1.0 110.053 169.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.78 165.69 30.19 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 107.707 -2.157 . . . . 1.0 107.707 169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -172.2 158.93 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.226 1.01 . . . . 1.0 110.463 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.4 135.2 39.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.743 -1.577 . . . . 1.0 106.743 168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -116.57 150.13 38.52 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.272 -1.751 . . . . 1.0 106.272 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -78.73 -124.0 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.357 -0.609 . . . . 1.0 109.357 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t 68.33 151.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.096 1.758 . . . . 1.0 107.456 -167.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -56.25 156.96 9.83 Favored Pre-proline 0 CA--C 1.544 0.728 0 O-C-N 121.128 -0.982 . . . . 1.0 110.737 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -78.8 -47.43 0.31 Allowed 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.322 -1.068 . . . . 1.0 109.322 -10.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.1 177.71 6.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.681 1.592 . . . . 1.0 110.282 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -63.94 122.95 17.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.853 -0.795 . . . . 1.0 108.853 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -120.88 145.31 47.77 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.647 1.579 . . . . 1.0 108.879 -173.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.16 146.62 52.3 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 32.1 mm -134.0 131.06 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 103.867 -2.642 . . . . 1.0 103.867 168.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.1 t -126.27 145.7 50.3 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 118.981 -0.533 . . . . 1.0 110.121 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -116.59 125.33 51.67 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.413 1.085 . . . . 1.0 111.198 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -114.6 147.03 37.21 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.671 1.189 . . . . 1.0 109.149 -172.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.69 80.92 1.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.998 3.798 . . . . 1.0 109.588 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.325 -0.458 0 C-N-CA 125.406 1.482 . . . . 1.0 112.776 -169.669 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -75.21 69.76 2.09 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.35 0.595 . . . . 1.0 109.943 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.14 169.63 13.16 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.379 1.471 . . . . 1.0 110.484 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 99.2 m -131.91 147.55 52.48 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 168.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -112.57 149.14 33.16 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.03 115.99 32.92 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 127.089 2.156 . . . . 1.0 106.326 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -64.59 -170.38 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.174 2.583 . . . . 1.0 111.404 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -50.38 153.32 1.57 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.956 0.902 . . . . 1.0 113.098 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.72 -51.78 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.26 -1.536 . . . . 1.0 109.26 -171.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -82.39 -47.88 11.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 105.38 -2.082 . . . . 1.0 105.38 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -76.94 145.83 37.93 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 168.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -88.28 74.05 8.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.983 0.896 . . . . 1.0 112.503 -169.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 70.77 -102.31 1.03 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.875 169.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.7 t -75.86 135.79 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.1 p -108.42 -54.84 2.46 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.582 0.586 . . . . 1.0 112.582 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.83 -58.8 0.74 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 123.596 0.617 . . . . 1.0 112.771 -170.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -98.03 115.26 27.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.401 1.48 . . . . 1.0 112.646 -169.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.431 ' HA ' ' H ' ' A' ' 36' ' ' CYS . 14.6 t-20 -57.45 -61.72 2.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.086 1.354 . . . . 1.0 113.437 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -49.04 -44.76 41.94 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.714 1.206 . . . . 1.0 111.032 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 -55.4 25.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -51.67 -54.12 31.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.995 0.426 . . . . 1.0 110.817 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 ttmm -49.18 -64.84 0.69 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.234 1.413 . . . . 1.0 110.682 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -55.12 -61.89 2.02 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -51.84 -43.78 63.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.673 -0.68 . . . . 1.0 110.44 -174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -55.97 -65.87 0.53 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.915 0.779 . . . . 1.0 112.033 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 pt -70.87 -15.25 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.317 0.58 . . . . 1.0 111.969 -169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -82.49 -56.17 4.04 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.392 1.477 . . . . 1.0 108.913 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.7 -64.03 0.98 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.777 0.431 . . . . 1.0 110.529 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -88.98 -176.14 5.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.142 -1.429 . . . . 1.0 107.142 173.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -115.77 13.11 16.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.448 1.277 . . . . 1.0 114.448 -168.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -41.68 159.48 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.582 1.553 . . . . 1.0 113.117 169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -88.75 -62.35 1.51 Allowed 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.811 -0.555 . . . . 1.0 111.36 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -105.61 161.13 14.64 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.459 -0.941 . . . . 1.0 108.459 177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.53 155.84 27.16 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 107.167 -2.373 . . . . 1.0 107.167 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.18 134.7 0.73 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.112 -1.07 . . . . 1.0 108.112 -171.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 18' ' ' ASN . 51.4 t -74.91 122.69 23.82 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 169.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.44 156.09 18.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.142 1.777 . . . . 1.0 109.059 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -122.54 46.84 2.05 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 114.614 1.338 . . . . 1.0 114.614 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -67.5 143.84 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 104.221 -2.511 . . . . 1.0 104.221 166.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -55.41 161.01 3.15 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.479 0.712 . . . . 1.0 111.921 -175.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.99 -40.66 0.86 Allowed 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.729 0.939 . . . . 1.0 110.61 -10.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.47 161.07 16.52 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.384 1.474 . . . . 1.0 111.026 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -64.22 151.25 44.05 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.277 1.431 . . . . 1.0 110.939 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -139.59 131.97 28.46 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.734 0.814 . . . . 1.0 110.57 -175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.86 102.25 12.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.37 132.67 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 107.396 -1.335 . . . . 1.0 107.396 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.5 t -131.33 148.54 52.68 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.307 -0.854 . . . . 1.0 110.563 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -123.83 134.92 53.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.581 1.152 . . . . 1.0 114.053 -168.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.01 146.99 59.71 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.427 1.491 . . . . 1.0 109.339 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.03 77.2 3.86 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 125.12 3.88 . . . . 1.0 110.845 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p . . . . . 0 C--N 1.326 -0.434 0 C-N-CA 124.13 0.972 . . . . 1.0 111.196 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 119.472 -0.299 . . . . 1.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -50.26 120.36 4.46 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.954 0.902 . . . . 1.0 109.96 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 67.9 mt -86.96 163.15 17.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.5 m -139.53 139.59 36.94 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 128.359 2.664 . . . . 1.0 104.396 167.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -84.4 148.91 26.34 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.462 0.305 . . . . 1.0 110.762 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -135.26 128.17 18.26 Favored Pre-proline 0 N--CA 1.449 -0.5 0 C-N-CA 126.479 1.911 . . . . 1.0 106.51 172.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.51 -91.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.026 1.818 . . . . 1.0 108.223 169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -72.62 83.53 1.14 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 121.266 -0.896 . . . . 1.0 109.812 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.0 -86.08 1.57 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 106.204 -2.758 . . . . 1.0 106.204 169.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -84.41 -70.59 0.56 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.866 -1.901 . . . . 1.0 105.866 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.65 76.52 0.11 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.426 1.49 . . . . 1.0 111.433 -173.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -89.75 64.9 6.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.198 0.999 . . . . 1.0 109.647 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.48 -173.11 41.82 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.455 -0.658 . . . . 1.0 111.455 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.45 140.02 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.497 -0.927 . . . . 1.0 108.497 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -36.49 67.45 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 -168.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.26 -46.74 0.83 Allowed Glycine 0 CA--C 1.539 1.562 0 CA-C-O 119.484 -0.62 . . . . 1.0 114.028 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -173.47 135.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.848 1.324 . . . . 1.0 111.981 -169.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -50.32 -61.86 1.93 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.396 1.479 . . . . 1.0 112.954 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -55.54 -46.97 77.02 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.446 0.698 . . . . 1.0 111.627 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.58 -54.57 44.93 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.28 -0.267 . . . . 1.0 110.28 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -48.84 -56.14 9.58 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.653 0.781 . . . . 1.0 110.991 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -48.84 -64.27 0.85 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.719 1.608 . . . . 1.0 110.417 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -53.19 -62.77 1.44 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 -174.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -52.13 -44.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 118.578 -0.725 . . . . 1.0 110.887 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.44 -63.78 1.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 119.111 -1.036 . . . . 1.0 112.089 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.0 pt -72.3 -15.88 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.432 0.634 . . . . 1.0 111.529 -169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -82.0 -58.24 3.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.861 1.264 . . . . 1.0 108.878 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.39 -62.36 1.42 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.825 0.45 . . . . 1.0 110.319 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -89.16 175.22 7.46 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.29 10.7 mmtm -105.51 16.43 25.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.038 1.496 . . . . 1.0 115.038 -168.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -39.49 -179.63 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.536 2.334 . . . . 1.0 115.164 169.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.7 mmt-85 -112.16 -64.15 1.33 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.698 -1.251 . . . . 1.0 111.261 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -105.79 157.32 17.53 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.08 150.71 21.94 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 107.216 -2.353 . . . . 1.0 107.216 169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.5 m -171.29 152.49 3.37 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.144 0.978 . . . . 1.0 108.9 -174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.8 t -84.14 130.93 34.82 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.106 -0.952 . . . . 1.0 109.619 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -107.98 153.64 22.78 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.617 1.167 . . . . 1.0 108.505 171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -83.21 -109.53 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 169.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.9 t 61.71 150.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.61 1.564 . . . . 1.0 109.545 -168.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -57.71 157.41 14.62 Favored Pre-proline 0 CA--C 1.542 0.653 0 O-C-N 120.897 -1.127 . . . . 1.0 110.493 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -45.18 0.43 Allowed 'Cis proline' 0 N--CA 1.452 -0.963 0 N-CA-C 109.384 -1.044 . . . . 1.0 109.384 -10.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 174.17 9.09 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.593 1.557 . . . . 1.0 109.678 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -63.84 138.41 58.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.832 0.453 . . . . 1.0 110.114 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.4 ptpp? -133.32 134.09 43.37 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.554 1.142 . . . . 1.0 109.519 -172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 44.3 t -75.51 126.57 31.27 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.63 141.47 25.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.077 -1.453 . . . . 1.0 107.077 172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.6 t -137.65 152.77 49.68 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.929 0.492 . . . . 1.0 110.112 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -125.09 120.53 31.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.29 0.636 . . . . 1.0 110.015 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 1.8 m-30 -111.81 147.89 37.8 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 124.238 1.015 . . . . 1.0 108.696 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -63.11 127.98 21.65 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.18 2.587 . . . . 1.0 108.835 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.221 0 C-N-CA 123.002 0.521 . . . . 1.0 110.052 -171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.45 135.58 50.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.01 0.524 . . . . 1.0 111.429 -176.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 42.0 mt -69.71 157.52 37.12 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.364 0.602 . . . . 1.0 112.493 -176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.6 m -135.04 145.28 47.85 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 127.718 2.407 . . . . 1.0 105.162 168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -97.93 148.19 23.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.006 0.922 . . . . 1.0 111.399 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -130.77 127.3 22.17 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 104.961 -2.237 . . . . 1.0 104.961 167.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -83.04 -143.46 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.995 2.463 . . . . 1.0 108.408 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -3.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 129.318 3.047 . . . . 1.0 117.803 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.44 40.94 0.63 Allowed Glycine 0 CA--C 1.532 1.12 0 CA-C-N 120.868 1.667 . . . . 1.0 113.346 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.42 -64.26 0.11 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.473 2.309 . . . . 1.0 105.154 168.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -84.61 80.85 9.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.375 -1.343 . . . . 1.0 107.375 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 m -87.95 66.73 8.79 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.691 0.758 . . . . 1.0 109.354 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.89 -173.06 40.41 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 107.754 -2.138 . . . . 1.0 107.754 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.02 135.95 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 p -74.12 -21.03 60.05 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 113.137 0.792 . . . . 1.0 113.137 -169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.49 -51.25 2.57 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.431 -0.649 . . . . 1.0 113.165 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.6 141.82 2.99 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.737 1.268 . . . . 1.0 112.095 -169.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -45.55 -62.05 1.44 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.984 1.714 . . . . 1.0 113.048 175.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -65.29 -40.19 93.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.029 -0.987 . . . . 1.0 111.481 -173.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.8 -54.93 41.54 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -50.24 60.59 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.971 0.509 . . . . 1.0 110.68 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' HZ2' ' HB2' ' A' ' 22' ' ' LYS . 3.8 ttmp? -51.42 -65.28 0.58 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.008 1.323 . . . . 1.0 110.7 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -51.8 -62.21 1.77 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.23 -48.44 62.1 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 119.334 -0.365 . . . . 1.0 110.755 -173.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -56.28 -62.18 1.89 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.886 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 pt -72.63 -15.2 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.994 0.425 . . . . 1.0 111.421 -170.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -80.19 -60.99 2.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.27 -1.011 . . . . 1.0 108.27 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.61 -55.54 9.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.84 1.256 . . . . 1.0 110.287 -170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -98.85 177.68 5.2 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.13 13.94 26.82 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.908 -1.12 . . . . 1.0 112.682 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -42.24 150.59 0.13 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.198 0.999 . . . . 1.0 111.054 169.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -86.83 -54.74 4.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 O-C-N 122.185 -0.322 . . . . 1.0 111.233 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -108.55 159.81 16.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.543 -0.54 . . . . 1.0 109.543 171.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.98 142.79 10.02 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 105.51 -3.036 . . . . 1.0 105.51 168.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.52 98.78 0.19 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.842 1.321 . . . . 1.0 107.785 -171.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.6 t -73.21 142.83 47.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 109.009 -0.737 . . . . 1.0 109.009 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -137.4 165.4 26.33 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.701 1.2 . . . . 1.0 108.22 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -71.27 59.01 0.26 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.276 1.03 . . . . 1.0 110.787 170.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -77.45 102.18 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 104.16 -2.533 . . . . 1.0 104.16 168.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -41.68 150.13 0.37 Allowed Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.702 1.601 . . . . 1.0 113.558 -171.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -80.74 -65.88 0.03 OUTLIER 'Cis proline' 0 N--CA 1.452 -0.949 0 N-CA-C 109.079 -1.162 . . . . 1.0 109.079 -10.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.88 147.27 52.74 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.129 -0.357 . . . . 1.0 110.59 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -63.77 123.0 17.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.018 -1.475 . . . . 1.0 107.018 173.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -131.38 137.81 48.87 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.366 1.066 . . . . 1.0 110.245 -169.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 49.0 t -75.12 97.76 3.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.627 0.771 . . . . 1.0 111.037 -169.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.4 mm -79.42 123.98 37.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.788 -1.56 . . . . 1.0 106.788 171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.1 t -126.16 148.09 49.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.846 -0.597 . . . . 1.0 110.681 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -124.01 125.63 44.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.74 1.216 . . . . 1.0 112.239 -167.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -125.45 144.38 47.65 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 125.767 1.627 . . . . 1.0 107.885 -177.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -64.61 128.91 22.23 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.417 2.745 . . . . 1.0 108.832 173.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.154 0 CA-C-N 118.921 0.782 . . . . 1.0 112.436 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -73.03 72.46 1.14 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.912 -1.144 . . . . 1.0 107.912 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mt -73.22 165.38 25.15 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.792 0.837 . . . . 1.0 110.763 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.3 m -126.04 143.22 51.19 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -88.24 110.95 21.13 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.747 1.219 . . . . 1.0 110.423 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -99.07 119.23 61.24 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 107.765 -1.198 . . . . 1.0 107.765 169.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.29 -76.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.997 1.798 . . . . 1.0 108.29 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 p -82.12 82.0 7.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 120.935 -1.103 . . . . 1.0 109.746 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.04 -94.87 1.69 Allowed Glycine 0 CA--C 1.52 0.378 0 N-CA-C 105.619 -2.992 . . . . 1.0 105.619 169.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -84.77 -71.31 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.608 -1.627 . . . . 1.0 106.608 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.41 ' CE3' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t90 -67.99 74.07 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.137 1.375 . . . . 1.0 112.057 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 m -89.01 64.35 7.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.653 -0.654 . . . . 1.0 109.339 -175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.93 -173.56 44.35 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 112.179 -0.369 . . . . 1.0 112.179 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.2 t -63.91 149.09 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 108.35 -0.981 . . . . 1.0 108.35 174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.6 p -132.55 -51.41 0.93 Allowed 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.54 0.941 . . . . 1.0 113.54 -176.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -66.59 0.62 Allowed Glycine 0 CA--C 1.535 1.307 0 N-CA-C 111.693 -0.563 . . . . 1.0 111.693 -168.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -75.43 87.22 2.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.931 0.892 . . . . 1.0 111.684 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -34.92 -56.31 0.57 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.006 2.122 . . . . 1.0 112.799 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -47.21 -53.62 12.77 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 127.315 2.246 . . . . 1.0 112.188 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.63 -48.82 65.65 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -49.81 -55.23 14.93 Favored 'General case' 0 N--CA 1.461 0.117 0 O-C-N 123.522 0.514 . . . . 1.0 110.198 176.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -50.46 -65.54 0.54 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.235 1.414 . . . . 1.0 110.132 177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -53.79 -63.0 1.29 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.44 -48.9 47.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.998 0.519 . . . . 1.0 110.498 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -56.38 -61.94 2.06 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 120.008 -0.677 . . . . 1.0 111.818 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 pt -69.95 -15.68 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.952 0.406 . . . . 1.0 111.901 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -83.35 -61.09 1.94 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.956 1.302 . . . . 1.0 108.732 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.86 -60.07 2.54 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.755 0.822 . . . . 1.0 110.756 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.39 174.5 7.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.652 -1.61 . . . . 1.0 106.652 169.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.92 12.6 28.64 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.333 -1.479 . . . . 1.0 113.324 -168.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.3 157.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.624 1.57 . . . . 1.0 112.553 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -98.04 -54.46 3.08 Favored 'General case' 0 C--O 1.227 -0.093 0 O-C-N 122.099 -0.376 . . . . 1.0 111.35 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -107.58 166.6 10.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.394 0.543 . . . . 1.0 109.97 170.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.18 150.22 20.21 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 107.416 -2.274 . . . . 1.0 107.416 168.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 t -166.51 137.79 3.48 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.257 1.029 . . . . 1.0 109.009 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.2 m -81.18 79.3 7.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -52.61 149.47 5.94 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.835 0.454 . . . . 1.0 109.885 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -78.23 -111.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.0 t 61.76 150.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.861 1.664 . . . . 1.0 109.957 -168.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -52.56 150.12 9.72 Favored Pre-proline 0 CA--C 1.542 0.638 0 O-C-N 121.043 -1.035 . . . . 1.0 110.893 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -81.03 -44.79 0.41 Allowed 'Cis proline' 0 N--CA 1.45 -1.035 0 N-CA-C 109.777 -0.894 . . . . 1.0 109.777 -10.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.05 174.27 10.36 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.621 1.568 . . . . 1.0 110.125 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -63.89 126.52 27.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.771 0.828 . . . . 1.0 110.807 -176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -124.74 137.51 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.011 1.724 . . . . 1.0 109.023 -170.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.5 t -77.11 106.44 8.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.47 132.66 37.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 106.052 -1.833 . . . . 1.0 106.052 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -125.0 141.54 52.06 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.171 0.295 . . . . 1.0 110.601 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -107.74 112.12 24.64 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.984 0.914 . . . . 1.0 110.795 -168.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -104.3 144.71 29.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 1.0 109.408 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.28 74.09 4.78 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 125.054 3.836 . . . . 1.0 110.256 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.327 -0.397 0 C-N-CA 124.577 1.151 . . . . 1.0 111.502 -177.457 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 120.826 0.346 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -63.48 141.67 58.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.4 mt -55.13 153.84 6.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 m -98.41 103.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 106.479 -1.675 . . . . 1.0 106.479 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -71.58 103.67 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -79.97 135.95 54.74 Favored Pre-proline 0 C--O 1.235 0.309 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.64 -176.26 2.46 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.106 1.871 . . . . 1.0 107.475 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -75.72 82.26 2.69 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.625 0.726 . . . . 1.0 110.913 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.66 -31.52 40.31 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.583 1.087 . . . . 1.0 111.523 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 p -84.57 -68.45 0.72 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 173.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -77.29 70.44 3.69 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.853 1.261 . . . . 1.0 109.365 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 m -86.96 68.22 10.01 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.015 -1.053 . . . . 1.0 108.525 -174.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.3 -178.02 40.32 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 127.825 2.631 . . . . 1.0 106.861 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.78 135.83 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 118.075 0.938 . . . . 1.0 109.135 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -32.98 62.38 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 112.042 0.386 . . . . 1.0 112.042 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.39 -68.46 0.92 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.364 -0.687 . . . . 1.0 111.76 -169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -131.46 138.13 48.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 -168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -52.22 -62.49 1.61 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 126.615 1.966 . . . . 1.0 113.445 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.4 -44.59 68.83 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.495 1.118 . . . . 1.0 111.736 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -55.18 31.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -50.18 -52.28 36.78 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.888 0.475 . . . . 1.0 110.98 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -49.26 -62.8 1.34 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.026 2.13 . . . . 1.0 109.833 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -51.14 -61.23 2.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.96 -51.02 10.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.602 0.761 . . . . 1.0 111.412 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.6 t -59.92 -56.36 22.67 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 119.29 0.95 . . . . 1.0 110.608 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 pt -73.95 -15.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.188 0.518 . . . . 1.0 111.757 -173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -83.65 -56.93 3.45 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.326 1.45 . . . . 1.0 108.999 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.73 -66.13 0.63 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.728 0.811 . . . . 1.0 110.082 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.4 -179.94 5.95 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm -110.22 12.35 23.36 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.775 -1.203 . . . . 1.0 113.019 -169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -42.79 154.26 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.88 0.872 . . . . 1.0 111.589 169.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.91 -59.99 2.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.965 -0.54 . . . . 1.0 110.545 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -108.13 141.28 40.09 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.339 0.59 . . . . 1.0 110.637 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.69 153.17 20.34 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 106.297 -2.721 . . . . 1.0 106.297 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.52 110.24 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.043 1.421 . . . . 1.0 107.44 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.8 t -72.81 141.94 48.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.265 -0.643 . . . . 1.0 109.265 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -119.18 150.7 39.62 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.639 1.576 . . . . 1.0 108.181 -175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -79.43 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.4 t 67.11 154.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.692 1.597 . . . . 1.0 107.397 -168.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -57.82 157.05 16.1 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 121.089 -1.007 . . . . 1.0 110.897 -177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.52 -51.3 0.16 OUTLIER 'Cis proline' 0 N--CA 1.45 -1.049 0 N-CA-C 109.237 -1.101 . . . . 1.0 109.237 -10.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.58 176.98 5.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.442 1.497 . . . . 1.0 111.05 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -66.19 114.99 5.71 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.644 1.178 . . . . 1.0 108.715 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -103.44 123.4 46.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.918 1.287 . . . . 1.0 110.106 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.5 t -73.9 83.17 1.69 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mm -79.32 139.29 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.311 -1.366 . . . . 1.0 107.311 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 t -131.05 139.15 49.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -117.8 113.07 21.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.212 1.005 . . . . 1.0 111.892 -166.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -155.36 162.7 26.73 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 121.62 -0.675 . . . . 1.0 110.138 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.85 154.0 18.19 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.773 2.315 . . . . 1.0 111.637 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 119.048 -0.501 . . . . 1.0 110.835 -175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 106.042 -1.836 . . . . 1.0 106.042 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.03 140.52 9.0 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.326 1.05 . . . . 1.0 109.018 168.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mp -85.42 151.83 23.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 123.171 0.294 . . . . 1.0 111.391 -169.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.3 m -100.31 122.83 43.72 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.736 1.214 . . . . 1.0 107.973 177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 -83.19 86.59 7.0 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 126.076 1.751 . . . . 1.0 108.979 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.16 115.53 18.33 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.626 0.771 . . . . 1.0 109.008 175.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.6 -93.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.478 2.118 . . . . 1.0 109.166 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -73.0 163.77 27.69 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.322 0.964 . . . . 1.0 110.448 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.72 -83.08 0.1 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.666 -1.774 . . . . 1.0 108.666 171.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 p -83.98 -96.31 0.06 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 104.985 -2.228 . . . . 1.0 104.985 169.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -67.53 103.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 m -114.15 -27.5 7.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.897 1.279 . . . . 1.0 111.592 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.51 -158.19 20.56 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.176 0.893 . . . . 1.0 112.092 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.59 127.3 14.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.881 0.872 . . . . 1.0 109.405 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -76.37 -35.62 58.58 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.874 0.869 . . . . 1.0 111.714 -174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.51 -38.63 0.36 Allowed Glycine 0 CA--C 1.538 1.492 0 CA-C-O 119.36 -0.689 . . . . 1.0 114.795 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -169.41 130.97 1.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.196 1.498 . . . . 1.0 112.332 -169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -49.71 -57.02 8.07 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 125.631 1.572 . . . . 1.0 113.275 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -62.61 -46.96 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.977 0.911 . . . . 1.0 112.387 -173.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.68 75.68 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -51.45 -52.25 47.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.38 0.425 . . . . 1.0 110.617 177.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -51.01 -56.68 11.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.966 1.707 . . . . 1.0 110.283 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -55.02 -64.57 0.79 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -53.95 -41.6 67.95 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.74 -68.45 0.17 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.322 0.649 . . . . 1.0 110.858 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.41 -11.92 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.149 0.5 . . . . 1.0 112.33 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -86.46 -60.64 1.94 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.28 1.432 . . . . 1.0 109.747 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.68 -48.81 58.43 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.068 0.547 . . . . 1.0 110.528 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -101.17 176.12 5.36 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -101.6 12.88 36.46 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.076 -1.015 . . . . 1.0 112.686 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -38.12 157.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.058 1.743 . . . . 1.0 113.514 169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -56.05 2.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.598 0.759 . . . . 1.0 109.946 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -108.84 167.57 9.98 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.786 -0.572 . . . . 1.0 110.192 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.2 145.27 11.22 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 104.883 -3.287 . . . . 1.0 104.883 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.13 149.1 4.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 105.962 -1.866 . . . . 1.0 105.962 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -87.06 140.96 29.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.173 -0.441 . . . . 1.0 110.536 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -132.11 155.98 47.17 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.568 1.147 . . . . 1.0 108.436 171.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -75.7 108.7 8.72 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.951 0.796 . . . . 1.0 109.95 172.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.491 HG22 ' H ' ' A' ' 40' ' ' PHE . 6.7 p -161.1 178.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 105.574 -2.01 . . . . 1.0 105.574 170.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.491 ' H ' HG22 ' A' ' 39' ' ' VAL . 2.3 p90 -55.01 137.04 66.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 -169.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.3 -46.34 0.34 Allowed 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 119.559 0.878 . . . . 1.0 111.544 6.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.47 100.29 0.5 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.371 -1.714 . . . . 1.0 106.371 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 70.02 114.28 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 -168.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -131.2 137.83 49.12 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.849 0.86 . . . . 1.0 109.598 -172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.3 t -74.55 109.19 7.83 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.407 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.4 mm -86.55 137.58 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.756 -1.572 . . . . 1.0 106.756 170.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.7 t -121.54 139.5 53.42 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -123.4 119.15 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.23 0.923 . . . . 1.0 111.403 -168.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.57 139.66 21.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 123.87 0.868 . . . . 1.0 109.14 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.18 75.06 2.39 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.548 3.499 . . . . 1.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.326 -0.431 0 C-N-CA 125.686 1.594 . . . . 1.0 110.977 -175.329 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 107.533 -1.284 . . . . 1.0 107.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.66 148.02 21.11 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.381 0.272 . . . . 1.0 110.394 174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.05 160.55 20.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.669 0.787 . . . . 1.0 111.626 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.7 m -121.96 124.52 44.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 168.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.93 74.16 4.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.067 -1.086 . . . . 1.0 108.067 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.36 129.18 86.23 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -62.42 152.39 77.31 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 108.345 -1.444 . . . . 1.0 108.345 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.9 p -24.92 -67.44 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.629 1.972 . . . . 1.0 114.17 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.1 -47.97 3.82 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 -170.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 p -82.32 -59.45 2.54 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.833 1.253 . . . . 1.0 107.97 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -72.56 76.92 1.07 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.74 -0.837 . . . . 1.0 108.74 171.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.36 59.97 5.82 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -170.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.02 -175.75 40.41 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.665 -0.974 . . . . 1.0 110.665 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.49 138.5 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.137 -1.06 . . . . 1.0 108.137 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -73.48 -25.74 60.59 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 -168.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.33 -49.91 1.29 Allowed Glycine 0 CA--C 1.537 1.435 0 CA-C-N 118.492 0.587 . . . . 1.0 113.887 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -167.78 137.23 2.63 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.828 1.314 . . . . 1.0 111.613 -169.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.38 -60.39 3.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.536 1.534 . . . . 1.0 112.998 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -54.1 -47.69 71.51 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.072 0.949 . . . . 1.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.86 -54.39 45.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 122.34 -0.225 . . . . 1.0 110.425 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -54.48 22.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.008 0.523 . . . . 1.0 110.343 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -48.03 -63.69 1.0 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.817 2.047 . . . . 1.0 109.998 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -52.9 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 -176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -45.71 -51.15 12.9 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.42 0.688 . . . . 1.0 110.553 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -56.27 -62.78 1.48 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.514 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.0 pt -70.08 -15.77 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.891 0.376 . . . . 1.0 111.469 -171.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -82.54 -62.77 1.52 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.865 1.266 . . . . 1.0 108.833 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.2 mp -69.87 -60.11 2.51 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.665 0.786 . . . . 1.0 110.439 -176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -89.28 172.67 8.88 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.84 12.8 28.56 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.528 -1.357 . . . . 1.0 113.411 -168.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 158.14 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.224 1.01 . . . . 1.0 110.949 168.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -91.99 -65.24 1.02 Allowed 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.8 -0.563 . . . . 1.0 111.088 -169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -107.82 162.23 14.19 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.25 162.21 29.41 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.207 -1.957 . . . . 1.0 108.207 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.18 142.67 0.83 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 118.291 1.045 . . . . 1.0 108.665 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.5 t -84.36 136.29 33.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 169.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.69 155.21 25.96 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.614 1.566 . . . . 1.0 107.678 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -84.13 -111.75 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 119.044 -0.503 . . . . 1.0 110.786 172.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 m 53.86 162.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.831 2.452 . . . . 1.0 111.409 -167.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -60.35 155.51 46.99 Favored Pre-proline 0 CA--C 1.541 0.606 0 O-C-N 120.895 -1.128 . . . . 1.0 110.814 -174.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.25 -50.62 0.18 OUTLIER 'Cis proline' 0 N--CA 1.451 -0.974 0 N-CA-C 109.233 -1.103 . . . . 1.0 109.233 -10.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.14 172.47 7.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.573 1.549 . . . . 1.0 110.964 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -64.45 124.37 21.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.613 1.165 . . . . 1.0 109.078 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -123.31 132.76 54.11 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.979 1.312 . . . . 1.0 111.659 -168.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.5 t -86.5 109.1 18.86 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.73 1.212 . . . . 1.0 110.822 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.04 148.6 7.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.686 1.194 . . . . 1.0 108.511 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.9 t -142.94 147.21 34.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 111.913 0.338 . . . . 1.0 111.913 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -115.06 122.61 46.7 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.624 1.17 . . . . 1.0 111.74 -167.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 49' ' ' PHE . 0.1 OUTLIER -132.44 141.89 42.92 Favored Pre-proline 0 N--CA 1.446 -0.641 0 C-N-CA 125.399 1.479 . . . . 1.0 107.886 -178.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.6 75.46 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.726 1 C-N-CA 125.592 4.195 . . . . 1.0 110.256 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 124.582 1.153 . . . . 1.0 111.64 -175.511 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.24 -0.281 . . . . 1.0 110.24 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.25 151.94 6.78 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.073 0.549 . . . . 1.0 110.201 173.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.0 mt -81.13 157.84 25.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.21 0.529 . . . . 1.0 111.897 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -139.57 145.07 38.15 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.338 1.855 . . . . 1.0 107.259 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -87.65 137.68 32.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.512 1.525 . . . . 1.0 110.371 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.68 149.7 69.82 Favored Pre-proline 0 C--O 1.233 0.236 0 N-CA-C 105.631 -1.988 . . . . 1.0 105.631 169.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -60.18 129.38 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 N-CA-C 102.924 -3.529 . . . . 1.0 102.924 166.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.3 p -40.68 137.72 1.11 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -166.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -28.83 -60.2 0.15 Allowed Glycine 0 C--N 1.342 0.879 0 C-N-CA 126.853 2.168 . . . . 1.0 111.877 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 p -84.84 -74.32 0.4 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.389 1.476 . . . . 1.0 110.039 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -75.65 70.93 2.51 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.178 1.391 . . . . 1.0 110.05 -170.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.2 m -87.69 70.9 9.71 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.2 -166.56 21.19 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 115.848 -0.614 . . . . 1.0 111.839 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -64.39 131.15 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.183 0.993 . . . . 1.0 109.146 -175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.9 p -97.71 -55.98 2.65 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.925 0.89 . . . . 1.0 112.661 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.5 -48.1 1.49 Allowed Glycine 0 CA--C 1.538 1.508 0 CA-C-O 119.589 -0.561 . . . . 1.0 112.347 -169.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -130.52 125.59 34.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.944 1.297 . . . . 1.0 112.849 -171.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -46.21 -63.52 0.97 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.965 2.106 . . . . 1.0 112.666 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -55.53 -47.5 76.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.861 -1.063 . . . . 1.0 112.594 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.38 -57.83 11.2 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 123.507 0.504 . . . . 1.0 109.983 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.7 t -50.34 -54.19 23.42 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.504 0.722 . . . . 1.0 110.42 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -51.15 -62.75 1.42 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.12 1.368 . . . . 1.0 110.91 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -53.52 -66.91 0.31 Allowed 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -45.67 -48.58 14.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.872 0.869 . . . . 1.0 110.62 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -54.73 -64.81 0.72 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 118.253 0.479 . . . . 1.0 111.268 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.4 pt -75.32 -15.85 15.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-O 121.396 0.617 . . . . 1.0 111.402 -170.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -78.06 -54.19 6.55 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.059 -1.089 . . . . 1.0 108.059 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.5 mp -72.79 -72.15 0.26 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.1 pm0 -86.88 -179.43 6.52 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.443 -1.317 . . . . 1.0 107.443 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . 0.252 17.3 mmtm -113.68 13.29 18.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 -167.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -46.27 159.37 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.398 0.679 . . . . 1.0 110.254 168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -94.95 -57.46 2.43 Favored 'General case' 0 C--O 1.227 -0.084 0 O-C-N 121.362 -0.836 . . . . 1.0 112.75 -169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -106.19 163.29 12.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.12 151.88 23.6 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.497 -2.241 . . . . 1.0 107.497 169.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -166.75 169.88 12.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.896 0.855 . . . . 1.0 109.423 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.6 t -109.17 94.83 5.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.08 1.352 . . . . 1.0 108.152 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 151.03 23.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -82.25 -116.18 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.973 -0.691 . . . . 1.0 109.852 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.9 t 61.94 151.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.635 1.574 . . . . 1.0 108.619 -167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -56.5 157.05 10.37 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 120.786 -1.196 . . . . 1.0 110.832 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.86 -49.1 0.24 Allowed 'Cis proline' 0 N--CA 1.452 -0.937 0 N-CA-C 109.355 -1.056 . . . . 1.0 109.355 -10.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.43 173.45 7.65 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.742 1.617 . . . . 1.0 110.473 -174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -64.19 126.08 26.61 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.488 0.715 . . . . 1.0 109.193 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -123.14 138.44 54.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.021 1.728 . . . . 1.0 111.597 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.3 t -76.47 101.04 5.45 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.267 0.627 . . . . 1.0 110.59 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mm -91.1 144.04 9.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t -134.21 149.08 50.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.247 -0.433 . . . . 1.0 109.929 169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -113.7 117.68 32.21 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.044 1.337 . . . . 1.0 108.43 -168.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -119.2 152.75 52.72 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.16 -1.422 . . . . 1.0 107.16 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -57.27 127.62 26.33 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.151 2.567 . . . . 1.0 108.428 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 123.348 0.659 . . . . 1.0 112.264 -169.086 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.617 -0.142 . . . . 1.0 110.617 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -55.74 121.61 9.56 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.824 -0.436 . . . . 1.0 109.824 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.11 160.05 24.8 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.535 0.684 . . . . 1.0 112.82 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 88.1 m -138.15 142.28 40.11 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 128.315 2.646 . . . . 1.0 104.82 168.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -78.95 148.71 32.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.624 0.37 . . . . 1.0 110.104 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -131.81 87.62 44.64 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 106.37 -1.715 . . . . 1.0 106.37 168.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.06 -47.31 22.17 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.497 2.798 . . . . 1.0 112.013 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -71.96 82.47 0.94 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 170.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.4 -104.19 0.6 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 107.307 -2.317 . . . . 1.0 107.307 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -115.34 -76.79 0.57 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 104.098 -2.556 . . . . 1.0 104.098 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -64.92 74.04 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 128.074 2.549 . . . . 1.0 109.026 171.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.8 m -87.97 63.53 7.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.76 -163.9 21.39 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.59 0.55 . . . . 1.0 113.451 -170.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.1 t -62.44 132.14 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.289 1.035 . . . . 1.0 108.368 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.83 -38.13 8.78 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.25 -49.11 1.2 Allowed Glycine 0 CA--C 1.54 1.631 0 O-C-N 121.27 -0.894 . . . . 1.0 112.549 -168.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -144.64 130.36 19.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.855 1.328 . . . . 1.0 112.966 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -54.85 -59.07 5.23 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 126.161 1.784 . . . . 1.0 113.287 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.41 -45.05 69.21 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.575 1.15 . . . . 1.0 111.8 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.11 -54.36 45.57 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.2 t -51.68 -52.88 44.69 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.286 0.565 . . . . 1.0 110.799 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -47.8 -64.37 0.81 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.803 2.041 . . . . 1.0 110.763 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -51.46 -62.92 1.32 Allowed 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 124.438 1.086 . . . . 1.0 108.461 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -51.52 -45.55 62.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 119.121 -0.466 . . . . 1.0 111.666 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.39 -61.5 2.44 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.728 0.694 . . . . 1.0 111.734 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 pt -75.39 -14.6 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 1.0 111.409 -170.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -82.17 -58.78 2.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.729 1.212 . . . . 1.0 109.247 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.86 -62.16 1.49 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 119.26 -0.4 . . . . 1.0 110.249 -177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -89.83 -174.95 4.46 Favored 'General case' 0 C--N 1.341 0.204 0 N-CA-C 107.495 -1.298 . . . . 1.0 107.495 169.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -113.86 13.95 18.48 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.982 0.913 . . . . 1.0 112.388 -169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB2' ' CE2' ' A' ' 49' ' ' PHE . . . -43.94 154.76 0.09 Allowed 'General case' 0 C--N 1.339 0.124 0 CA-C-O 121.631 0.729 . . . . 1.0 111.391 169.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -89.14 -55.2 3.77 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.571 -169.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -108.74 156.22 19.85 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.014 -0.736 . . . . 1.0 109.014 168.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.45 144.81 14.18 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 104.209 -3.556 . . . . 1.0 104.209 168.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.6 114.26 0.05 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 -170.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 40.0 t -72.77 139.14 46.9 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 109.056 -0.72 . . . . 1.0 109.056 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -114.68 161.45 18.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.108 1.363 . . . . 1.0 108.41 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -83.65 -115.17 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 119.133 -0.46 . . . . 1.0 111.822 175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.256 15.3 m 54.91 160.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 128.014 2.526 . . . . 1.0 110.75 -166.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -59.37 155.58 35.83 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 120.839 -1.163 . . . . 1.0 110.965 -172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.44 -51.12 0.16 OUTLIER 'Cis proline' 0 N--CA 1.453 -0.909 0 N-CA-C 109.374 -1.048 . . . . 1.0 109.374 -10.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.55 174.0 6.82 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.834 1.654 . . . . 1.0 110.577 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -64.09 125.91 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.028 0.931 . . . . 1.0 108.857 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -123.7 133.57 53.86 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.029 1.331 . . . . 1.0 111.959 -169.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 40.9 t -76.85 86.54 3.42 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.07 0.462 . . . . 1.0 111.59 -171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.57 145.05 9.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 171.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.2 t -133.8 148.8 51.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.611 0.764 . . . . 1.0 110.1 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.37 135.5 46.18 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.422 1.089 . . . . 1.0 112.141 -167.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -133.84 144.96 53.99 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 -173.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -60.95 128.3 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.793 2.996 . . . . 1.0 108.978 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-N 118.171 0.441 . . . . 1.0 111.473 -173.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 110.486 -0.19 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.54 134.62 57.19 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.72 176.26 7.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.743 0.783 . . . . 1.0 112.717 -169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 93.3 m -139.51 104.59 4.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.979 -2.23 . . . . 1.0 104.979 168.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.52 72.87 1.01 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.239 1.016 . . . . 1.0 108.986 177.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -98.31 126.65 38.96 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 113.735 1.013 . . . . 1.0 113.735 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.79 -35.33 7.68 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 N-CA-C 106.759 -2.054 . . . . 1.0 106.759 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -70.32 82.89 0.55 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.85 1.66 . . . . 1.0 110.091 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.48 -103.57 0.48 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 106.242 -2.743 . . . . 1.0 106.242 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -92.7 -69.91 0.72 Allowed 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.815 0.816 . . . . 1.0 109.47 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -79.07 65.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.721 0.808 . . . . 1.0 112.381 -169.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m -87.96 62.52 6.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.69 -170.6 32.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.246 -0.742 . . . . 1.0 111.246 -174.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.95 133.36 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 p -92.34 -35.42 13.74 Favored 'General case' 0 C--O 1.226 -0.151 0 N-CA-C 114.17 1.174 . . . . 1.0 114.17 -169.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.03 -43.69 0.65 Allowed Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.373 -0.83 . . . . 1.0 113.483 -169.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -158.24 134.15 9.14 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.519 1.66 . . . . 1.0 113.4 -169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -58.18 -55.62 32.57 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 126.899 2.08 . . . . 1.0 113.482 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -54.6 -51.7 64.49 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.873 0.869 . . . . 1.0 111.625 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.52 -51.16 67.95 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 t -50.64 -54.37 23.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.154 0.284 . . . . 1.0 111.333 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -41.87 98.11 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 117.984 0.357 . . . . 1.0 111.218 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 -54.54 -66.76 0.34 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -53.96 -42.04 68.47 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.287 0.235 . . . . 1.0 111.403 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -48.77 -68.02 0.22 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.898 0.879 . . . . 1.0 112.059 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 pt -78.4 -15.36 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.488 0.661 . . . . 1.0 111.25 -169.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -79.36 -59.26 2.83 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.31 1.444 . . . . 1.0 109.243 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.47 -63.26 1.23 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.998 -0.525 . . . . 1.0 109.851 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -87.56 173.08 9.28 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.862 -1.533 . . . . 1.0 106.862 174.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -101.98 13.65 34.19 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 120.639 -1.288 . . . . 1.0 114.225 -168.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -40.35 158.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.984 1.714 . . . . 1.0 114.179 169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -83.77 -69.61 0.62 Allowed 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.057 0.543 . . . . 1.0 109.594 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -108.51 172.41 6.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.93 0.872 . . . . 1.0 110.562 169.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.11 166.8 30.57 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 105.484 -3.047 . . . . 1.0 105.484 169.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 m -173.81 146.35 1.24 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.878 -1.527 . . . . 1.0 106.878 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 54.1 t -95.56 138.55 33.07 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 108.686 -0.857 . . . . 1.0 108.686 169.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -133.26 162.64 31.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.15 121.06 14.32 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.936 -1.505 . . . . 1.0 106.936 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.9 t -143.37 118.23 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 103.85 -2.648 . . . . 1.0 103.85 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -38.77 138.08 0.82 Allowed Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 124.164 0.986 . . . . 1.0 112.951 -169.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -87.49 -7.12 51.42 Favored 'Cis proline' 0 N--CA 1.455 -0.77 0 CA-C-O 118.506 -0.706 . . . . 1.0 113.752 6.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.09 -165.12 2.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.712 1.142 . . . . 1.0 112.162 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -70.47 114.77 8.91 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -120.82 136.19 54.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.659 1.184 . . . . 1.0 109.726 -174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.0 t -74.21 130.81 40.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.319 0.648 . . . . 1.0 109.915 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 mm -116.92 133.42 63.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.125 -1.435 . . . . 1.0 107.125 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.5 t -124.63 131.39 53.47 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.046 0.939 . . . . 1.0 108.578 -176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -111.58 100.22 8.81 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.819 0.736 . . . . 1.0 111.471 -168.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.23 149.87 55.6 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 124.88 1.272 . . . . 1.0 109.709 -177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.98 68.55 4.82 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.701 2.934 . . . . 1.0 110.342 176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.151 -0.931 . . . . 1.0 110.191 -172.481 . . . . . . . . 1 1 . 1 stop_ save_